دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Patient-reported Goals in Inflammatory Bowel Disease: What’s the Problem?
Darren Wong, Simon P L Travis
doi : 10.1093/ecco-jcc/jjab156
Eating for Two: Diet and the Microbiome in Ulcerative Colitis
Svetlana F Lima, Randy S Longman
doi : 10.1093/ecco-jcc/jjab181
ECCO Topical Review on Clinicopathological Spectrum and Differential Diagnosis of Inflammatory Bowel Disease
Roger Feakins, Joana Torres, Paula Borralho-Nunes, Johan Burisch, Tiago Cúrdia Gonçalves, Lissy De Ridder, Ann Driessen, Triana Lobatón, Luis Menchén, Aart Mookhoek, Nurulamin Noor, Magali Svrcek, Vincenzo Villanacci, Nina Zidar, Monika Tripathi
doi : 10.1093/ecco-jcc/jjab141
Use of Faecal Transplantation with a Novel Diet for Mild to Moderate Active Ulcerative Colitis: The CRAFT UC Randomised Controlled Trial
Chen Sarbagili Shabat, Franco Scaldaferri, Eran Zittan, Ayal Hirsch, Maria Chiara Mentella, Tania Musca, Nathaniel Aviv Cohen, Yulia Ron, Naomi Fliss Isakov, Jorge Pfeffer, Michal Yaakov, Caterina Fanali, Laura Turchini, Luca Masucci, Gianluca Quaranta, Nitzan Kolonimos, Anastasia Godneva, Adina Weinberger, Uri Kopylov, Arie Levine, Nitsan Maharshak
doi : 10.1093/ecco-jcc/jjab165
Identifying and Predicting the Goals and Concerns Prioritised by Individuals with Inflammatory Bowel Disease
Chung Sang Tse, Aricca D Van Citters, Brittany Ricci, Noah Z Freundlich, Moses Lee, Samir A Shah, Gil Y Melmed, Corey A Siegel, Welmoed K van Deen, IBD Qorus
doi : 10.1093/ecco-jcc/jjab142
Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses: Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated Patients
Neil Chanchlani, Simeng Lin, Desmond Chee, Benjamin Hamilton, Rachel Nice, Zehra Arkir, Claire Bewshea, Bessie Cipriano, Lauranne A A P Derikx, Allan Dunlop, Louise Greathead, Rachel L Griffiths, Hajir Ibraheim, Peter Kelleher, Klaartje B Kok, Charlie W Lees, Jonathan MacDonald, Shaji Sebastian, Philip J Smith, Timothy J McDonald, Peter M Irving, Nick Powell, Nicholas A Kennedy, James R Goodhand, Tariq Ahmad
doi : 10.1093/ecco-jcc/jjab153
Machine Learning-based Prediction Models for Diagnosis and Prognosis in Inflammatory Bowel Diseases: A Systematic Review
Nghia H Nguyen, Dominic Picetti, Parambir S Dulai, Vipul Jairath, William J Sandborn, Lucila Ohno-Machado, Peter L Chen, Siddharth Singh
doi : 10.1093/ecco-jcc/jjab155
The Effect of Phenotype and Genotype on the Plasma Proteome in Patients with Inflammatory Bowel Disease
Arno R Bourgonje, Shixian Hu, Lieke M Spekhorst, Daria V Zhernakova, Arnau Vich Vila, Yanni Li, Michiel D Voskuil, Lisette A van Berkel, Brenda Bley Folly, Mohammed Charrout, Ahmed Mahfouz, Marcel J T Reinders, Julia I P van Heck, Leo A B Joosten, Marijn C Visschedijk, Hendrik M van Dullemen, Klaas Nico Faber, Janneke N Samsom, Eleonora A M Festen, Gerard Dijkstra, Rinse K Weersma
doi : 10.1093/ecco-jcc/jjab157
Orofacial Granulomatosis Associated with Crohn’s Disease: a Multicentre Case Series
Frank Phillips, Bram Verstockt, Malgorzata Sladek, Nanne de Boer, Konstantinos Katsanos, Konstantinos Karmiris, Ahmad Albshesh, Carl Erikson, Daniel Bergemalm, Tamas Molnar, Pierre Ellul ECCO CONFER Investigators
doi : 10.1093/ecco-jcc/jjab158
Risk of Neurodegenerative Diseases in Patients with Inflammatory Bowel Disease: A Nationwide Population-based Cohort Study
Ga Hee Kim, Yeong Chan Lee, Tae Jun Kim, Eun Ran Kim, Sung Noh Hong, Dong Kyung Chang, Young-Ho Kim
doi : 10.1093/ecco-jcc/jjab162
Association Between Proposed Definitions of Clinical Remission/Response and Well-Being in Patients With Crohn’s Disease
William J Sandborn, James D Lewis, Julian Panes, Edward V Loftus, Geert D’Haens, Zhuqing Yu, Bidan Huang, Ana P Lacerda, Aileen L Pangan, Brian G Feagan
doi : 10.1093/ecco-jcc/jjab161
The Process of Developing a Disease Activity Index in Microscopic Colitis
Katarina Pihl Lesnovska, Andreas Münch, Ole Bonderup, Fernando Magro, Juozas Kupcinskas, Yamile Zabana, Gian Eugenio Tontini, Lars Kristian Munck, Danila Guagnozzi, Giovanni Latella,Fernando Fernandez-Banares, Stephan Miehlke, Ahmed Madisch, Signe Wildt, Henrik Hjortswang
doi : 10.1093/ecco-jcc/jjab170
Application of Artificial Intelligence to Clinical Practice in Inflammatory Bowel Disease – What the Clinician Needs to Know
David Chen, Clifton Fulmer, Ilyssa O Gordon, Sana Syed, Ryan W Stidham, Niels Vande Casteele, Yi Qin, Katherine Falloon, Benjamin L Cohen, Robert Wyllie, Florian Rieder
doi : 10.1093/ecco-jcc/jjab169
The Complex Relationship Between Microbiota, Immune Response and Creeping Fat in Crohn’s Disease
Roger Suau, Eva Pardina, Eugeni Domènech, Violeta Lorén, Josep Manyé
doi : 10.1093/ecco-jcc/jjab159
The Relationship Between Endoscopic and Clinical Recurrence in Postoperative Crohn’s Disease: A Systematic Review and Meta-analysis
Alessandro Ble, Cecilia Renzulli, Fabio Cenci, Maria Grimaldi, Michelangelo Barone, Rocio Sedano, Joshua Chang, Tran M Nguyen, Malcolm Hogan, Guangyong Zou, John K MacDonald, Christopher Ma, William J Sandborn, Brian G Feagan, Emilio Merlo Pich, Vipul Jairath
doi : 10.1093/ecco-jcc/jjab163
Diagnosis and Outcome of Extranodal Primary Intestinal Lymphoma in Inflammatory Bowel Disease: An ECCO CONFER Case Series
Frank Phillips, Bram Verstockt, Davide Giuseppe Ribaldone, Ivan Guerra, Niels Teich, Konstantinos Katsanos, Rafal Filip, Tamas Molner, Konstantinos Karmiris, ECCO CONFER Investigators
doi : 10.1093/ecco-jcc/jjab164
Mesenchymal Stem Cell Injection in Crohn’s Disease Strictures: A Phase I–II Clinical Study
Sophie Vieujean, Jean-Philippe Loly, Layla Boutaffala, Paul Meunier, Catherine Reenaers, Alexandra Briquet, Chantal Lechanteur, Etienne Baudoux, Yves Beguin, Edouard Louis
doi : 10.1093/ecco-jcc/jjab154
Perineal Outcomes After Delivery in 179 Mothers with Inflammatory Bowel Disease Compared to 31 258 Controls: A Single-Centre Cohort Study
Gillian Lever, Hlupe Chipeta, Tracey Glanville, Christian Selinger
doi : 10.1093/ecco-jcc/jjab151
Is Also the Patient Ready for Switching from Intravenous to Subcutaneous Biologics?
Katrien Asnong, Lieven Pouillon, Peter Bossuyt
doi : 10.1093/ecco-jcc/jjab152
